Home » Stock Quotes » EBR:ASIT

Asit Biotech SA

EBR:ASIT Share Price & Live Data

0.20 EUR
-0.01 (-6.67%)
Price open 0.21
Previous close 0.21
Market cap 4.29M
Volume 28.49K
Day high 0.21
Day low 0.19
Year high 3.04
Year low 0.15

About Asit Biotech SA

ASIT Biotech S.A., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead compound is gp-ASIT+, a phase III trial for the treatment of grass pollen allergy administered by subcutaneous injections. It also develops hdm-ASIT+ for the treatment of house dust mite rhinitis; and pnt-ASIT+ for the treatment of peanut allergy. The company was formerly known as BioTech Tools SA and changed its name to ASIT Biotech S.A. in August 2015. ASIT Biotech S.A. was founded in 1997 and is based in Woluwe-Saint-Lambert, Belgium.

Name Asit Biotech SA
Exchange Brussels Stock Exchange
Sector Healthcare
Industry Biotechnology
Country Belgium
Full time employees 23

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.